Novavax Inc. buy jomobb
.jpg?locale=us "jomobb")
Start price
28.05.21
/
80%
€125.18
Target price
28.05.22
€200.00
Performance (%)
-35.69%
End price
29.01.22
€80.50
Summary
This prediction ended on 29.01.22 with a price of €80.50. The BUY prediction by jomobb for Novavax Inc. performed very badly with a performance of -35.69%. jomobb has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novavax Inc. | -12.457% | -12.457% | 19.129% | 9.548% |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % | 44,61 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % | 70,74 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % | 48,21 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % | 54,25 % |
According to jomobb what are the pros and cons of Novavax Inc. for the foreseeable future?
Pros
Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Some uniques
Cons
Significant cyclical dependencies